Highlights
- Market Cap
- $1.68B
- Enterprise Value
- $1.61B
- EPS (TTM)
- -$1.73
- Total Revenue (TTM)
- $211.08M
- Gross Profit (TTM)
- $146.31M
- EBITDA (TTM)
- -$24.48M
- Year Range
- $26.56 - $83.31
- Target Price
- $85.00
- ROA (TTM)
- -14.30%
- ROE (TTM)
- -216.86%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Establishment Labs Holdings Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Establishment Labs Holdings Inc (ESTA) has returned -22.09% so far this year and 39.15% over the past 12 months.
Establishment Labs Holdings Inc
- 1D
- 3.82%
- 1M
- -27.85%
- YTD
- -22.09%
- 6M
- 38.52%
- 1Y
- 39.15%
- 3Y*
- -5.71%
- 5Y*
- -2.99%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jul 19, 2018, ESTA's average daily return is +0.13%, while the average monthly return is +2.23%. At this rate, your investment would double in approximately 2.6 years.
Historically, 54% of months were positive and 46% were negative. The best month was Jan 2024 with a return of +48.7%, while the worst month was Oct 2023 at -40.3%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.
On a daily basis, ESTA closed higher 50% of trading days. The best single day was Mar 19, 2020 with a return of +54.8%, while the worst single day was Mar 18, 2020 at -48.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.49% | 15.48% | -27.85% | -22.09% | |||||||||
| 2025 | -30.43% | 33.76% | -4.82% | -25.62% | 13.41% | 24.08% | -1.77% | -1.63% | -0.68% | 16.98% | 44.50% | 5.18% | 58.19% |
| 2024 | 48.71% | 18.65% | 11.43% | -1.75% | 4.44% | -13.00% | -2.20% | 3.11% | -5.57% | -0.42% | 6.50% | 0.39% | 77.95% |
| 2023 | 3.64% | 5.32% | -5.47% | 2.88% | -7.42% | 6.34% | 4.96% | -16.16% | -18.72% | -40.33% | -12.40% | 0.94% | -60.56% |
| 2022 | -22.56% | 15.46% | 11.52% | 5.00% | -12.80% | -11.86% | 9.03% | 4.87% | -12.17% | 3.26% | 13.07% | 2.96% | -2.87% |
| 2021 | 34.46% | 36.40% | -9.42% | 16.17% | 9.86% | 9.45% | -9.22% | -5.41% | -4.56% | 13.91% | -20.85% | 4.73% | 79.57% |
Benchmark Metrics
Establishment Labs Holdings Inc has an annualized alpha of 18.17%, beta of 1.30, and R² of 0.15 versus S&P 500 Index. Calculated based on daily prices since July 20, 2018.
- This stock captured 128.75% of S&P 500 Index gains and 124.97% of its losses — amplifying both gains and losses, but participating more in upside than downside.
- R² of 0.15 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 18.17%
- Beta
- 1.30
- R²
- 0.15
- Upside Capture
- 128.75%
- Downside Capture
- 124.97%
Return for Risk
Risk / Return Rank
ESTA ranks 63 for risk / return — better than 63% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Establishment Labs Holdings Inc (ESTA) and compare them to a chosen benchmark (S&P 500 Index).
| ESTA | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.57 | 0.90 | -0.32 |
Sortino ratioReturn per unit of downside risk | 1.28 | 1.39 | -0.11 |
Omega ratioGain probability vs. loss probability | 1.17 | 1.21 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.18 | 1.40 | -0.22 |
Martin ratioReturn relative to average drawdown | 2.98 | 6.61 | -3.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore ESTA risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Establishment Labs Holdings Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Establishment Labs Holdings Inc was 75.42%, occurring on Nov 10, 2023. The portfolio has not yet recovered.
The current Establishment Labs Holdings Inc drawdown is 35.63%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -75.42% | Jul 2, 2021 | 595 | Nov 10, 2023 | — | — | — |
| -73.91% | Jan 10, 2020 | 47 | Mar 18, 2020 | 182 | Dec 4, 2020 | 229 |
| -38.73% | Mar 21, 2019 | 142 | Oct 10, 2019 | 58 | Jan 3, 2020 | 200 |
| -25.35% | Sep 5, 2018 | 39 | Oct 29, 2018 | 96 | Mar 20, 2019 | 135 |
| -23.33% | Feb 24, 2021 | 24 | Mar 29, 2021 | 18 | Apr 23, 2021 | 42 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Establishment Labs Holdings Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Establishment Labs Holdings Inc is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ESTA relative to other companies in the Medical Devices industry. Currently, ESTA has a P/S ratio of 8.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ESTA in comparison with other companies in the Medical Devices industry. Currently, ESTA has a P/B value of 71.4. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |